hexoprenaline has been researched along with Coronary Disease in 1 studies
Hexoprenaline: Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lechner, W | 1 |
| Artner-Dworzak, E | 1 |
| Heim, K | 1 |
| Marth, C | 1 |
| Puschendorf, B | 1 |
1 other study available for hexoprenaline and Coronary Disease
| Article | Year |
|---|---|
Determination of light-chain myosin in pregnancy and under tocolysis.
Topics: Coronary Disease; Female; Hexoprenaline; Humans; Immunoenzyme Techniques; Metoprolol; Myosins; Pregn | 1989 |